IL186278A0 - Methods of preparing anhydrous aripiprazole form ii - Google Patents

Methods of preparing anhydrous aripiprazole form ii

Info

Publication number
IL186278A0
IL186278A0 IL186278A IL18627807A IL186278A0 IL 186278 A0 IL186278 A0 IL 186278A0 IL 186278 A IL186278 A IL 186278A IL 18627807 A IL18627807 A IL 18627807A IL 186278 A0 IL186278 A0 IL 186278A0
Authority
IL
Israel
Prior art keywords
methods
anhydrous aripiprazole
preparing anhydrous
aripiprazole form
preparing
Prior art date
Application number
IL186278A
Original Assignee
Teva Pharma
Eisen Nevo Hagit
Pavlov Zhanna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma, Eisen Nevo Hagit, Pavlov Zhanna filed Critical Teva Pharma
Publication of IL186278A0 publication Critical patent/IL186278A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IL186278A 2005-09-29 2007-09-25 Methods of preparing anhydrous aripiprazole form ii IL186278A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US72261605P 2005-09-29 2005-09-29
US72645605P 2005-10-12 2005-10-12
US73709205P 2005-11-15 2005-11-15
PCT/US2006/038279 WO2007041414A1 (en) 2005-09-29 2006-09-29 Methods of preparing anhydrous aripiprazole form ii

Publications (1)

Publication Number Publication Date
IL186278A0 true IL186278A0 (en) 2008-01-20

Family

ID=37670930

Family Applications (1)

Application Number Title Priority Date Filing Date
IL186278A IL186278A0 (en) 2005-09-29 2007-09-25 Methods of preparing anhydrous aripiprazole form ii

Country Status (7)

Country Link
EP (1) EP1934183A1 (en)
JP (1) JP2008521835A (en)
KR (1) KR20070088750A (en)
BR (1) BRPI0606163A2 (en)
IL (1) IL186278A0 (en)
MX (1) MX2007006368A (en)
WO (1) WO2007041414A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101340214B1 (en) * 2011-03-31 2013-12-10 주식회사 대웅제약 Process for the preparation of anhydrous Aripiprazole crystal form II
CN102850268B (en) * 2011-06-27 2015-07-15 上海中西制药有限公司 Aripiprazole I-type crystallite, aripiprazole solid preparation and preparation methods thereof
KR101372840B1 (en) * 2012-08-02 2014-03-12 주식회사 에스텍파마 Process for preparing anhydrous aripiprazole crystal

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006528A (en) 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
JP2608788B2 (en) 1988-10-31 1997-05-14 大塚製薬 株式会社 Schizophrenia remedy
AR033485A1 (en) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd MEDICINAL SUBSTANCE OF ARIPIPRAZOL OF LOW HYGROSCOPICITY AND PROCESS FOR THE PREPARATION OF THE SAME
ATE529409T1 (en) * 2003-12-16 2011-11-15 Teva Pharma METHOD FOR PRODUCING CRYSTALLINE FORMS OF ARIPIPRAZOLE

Also Published As

Publication number Publication date
KR20070088750A (en) 2007-08-29
BRPI0606163A2 (en) 2009-05-26
EP1934183A1 (en) 2008-06-25
MX2007006368A (en) 2007-07-11
JP2008521835A (en) 2008-06-26
WO2007041414A1 (en) 2007-04-12

Similar Documents

Publication Publication Date Title
EP1906830A4 (en) Extending intrabody capsule
IL183185A0 (en) Process of making crystalline aripiprazole
GB0522765D0 (en) Combination vaccine manufacture
IL184036A0 (en) Preparation of rosuvastatin
PL1844036T3 (en) Process for the preparation of aripiprazole
HK1119708A1 (en) Methods of preparing quinolone analogs
IL185757A0 (en) Methods of decreasing calcifcation
HK1122991A1 (en) External preparation for skin
IL186871A0 (en) External preparation for skin
EP1912499A4 (en) Preparation of montelukast
SI2093217T1 (en) Process for preparing Form X of aripiprazole
EP2212251A4 (en) Methods of preparing clusterboron
HK1099298A1 (en) Improved process for preparing rebamipide
IL190865A0 (en) Formulations of quinolinones
EP1919477A4 (en) Method of improving wakefulness
HK1161122A1 (en) Use of 24-norudca 24-norudca
EP1964538A4 (en) Preparation method of pharmaceutials
EP1890761A4 (en) Methods of increasing lipolysis
IL175966A0 (en) Process for preparing aripiprazole
EP1917231A4 (en) Process of preparing bromopicrin
IL186278A0 (en) Methods of preparing anhydrous aripiprazole form ii
EP2205525A4 (en) Methods of preparing clusterboron
IL187948A0 (en) Preparation of rosuvastatin
IL183378A0 (en) Methods of making pravastatin sodium
EP2205524A4 (en) Methods of preparing clusterboron